The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT ID: NCT02240615
Last Updated: 2016-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
10 participants
INTERVENTIONAL
2014-10-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora
NCT01010659
Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.
NCT05771012
Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients
NCT01957670
Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora
NCT01282541
Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness
NCT05778942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sinopsys Lacrimal Stent
All enrolled patients will receive a Sinopsys Lacrimal Stent inserted from the caruncle to the ethmoid sinus. Discharge instructions will include administration of sterile saline and ophthalmic drops as well as assessments for device patency.
Sinopsys Lacrimal Stent
Procedural insertion of the Sinopsys Lacrimal Stent in patients with epiphora
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sinopsys Lacrimal Stent
Procedural insertion of the Sinopsys Lacrimal Stent in patients with epiphora
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Keros classification 1 or 2 skull base anatomy
Exclusion Criteria
* Craniofacial deformity
* Severe inflammatory disease
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sinopsys Surgical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harry Ross, MD
Role: STUDY_DIRECTOR
Sinopsys Surgical Inc.
Teena Augostino
Role: STUDY_DIRECTOR
Sinopsys Surgical Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
University of Colorado Health Sciences Center
Aurora, Colorado, United States
Center for Sight
Sarasota, Florida, United States
Eye Care Specialists
Kingston, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SLS-US-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.